Previous studies have shown that H19 promotes cancer development through different mechanisms, as examples: in gastric cancer through Fas-related protein, in cholangiocarcinoma through IL-6 and CXCR4, in colorectal cancer through HMGA1, and in multiple myeloma through P50/P65 [23–26]. This evidence concerns the gene H19 and gastric cancer.